CorrespondencePregnancy after ovarian superovulation by transdermal delivery of follicle-stimulating hormone
Under an Elsevier user license
open archive
Key Words
Transdermal drug delivery
laser skin microporation
large molecular weight compound
ovarian superovulation
hyperstimulation
follicle stimulating hormone
pregnancy
Cited by (0)
N.H.Z. has nothing to disclose. M.M. has nothing to disclose. P.U. has nothing to disclose.
Pantec Biosolutions (Ruggell, Liechtenstein) sponsored the clinical study in Pilsen, Czech Republic.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.